Trial Profile
Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
Status:
Not yet recruiting
Phase of Trial:
Phase 0
Latest Information Update: 03 Feb 2022
Price :
$35
*
At a glance
- Drugs Dental pulp derived mesenchymal stem cells Shanghai-Biotechnology (Primary)
- Indications COVID 2019 infections; Pneumonia
- Focus Therapeutic Use
- Sponsors Shanghai Biotechnology
- 17 Mar 2020 New trial record